Insulin-like growth factor 1 signaling in human gastrointestinal carcinoid tumor cells.

[1]  T. Warner,et al.  Gastrointestinal Carcinoid Tumors: Factors that Predict Outcome , 2004, World Journal of Surgery.

[2]  E. K. Maloney,et al.  An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation. , 2003, Cancer research.

[3]  Herb Chen,et al.  Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cells. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[4]  Herb Chen,et al.  Activation of the ras/raf-1 signal transduction pathway in carcinoid tumor cells results in morphologic transdifferentiation. , 2002, Surgery.

[5]  Magnus Bosse,et al.  Regulation of Raf-Akt Cross-talk , 2002, The Journal of Biological Chemistry.

[6]  A. Hoeflich,et al.  Insulin-like growth factor-I is an autocrine regulator of chromogranin A secretion and growth in human neuroendocrine tumor cells. , 2000, Cancer research.

[7]  H. Fehmann,et al.  mRNA expression patterns of insulin‐like growth factor system components in human neuroendocrine tumours , 2000, European journal of clinical investigation.

[8]  I. McCutcheon,et al.  The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. , 2000, Endocrine reviews.

[9]  P. Cohen,et al.  Role of insulin‐like growth factors and their binding proteins in growth control and carcinogenesis , 2000, Journal of cellular physiology.

[10]  Modlin,et al.  Review article: current status of gastrointestinal carcinoids , 1999, Alimentary pharmacology & therapeutics.

[11]  K. Reiss,et al.  Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  C. Miller,et al.  Therapeutic alternatives in metastatic neuroendocrine tumors. , 1998, Surgical oncology clinics of North America.

[13]  M. Choti,et al.  Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? , 1998, Journal of the American College of Surgeons.

[14]  I. Modlin,et al.  An analysis of 8305 cases of carcinoid tumors , 2000, Cancer.

[15]  W. Creutzfeldt.  Carcinoid Tumors: Development of Our Knowledge , 1996, World Journal of Surgery.

[16]  D. Leroith,et al.  Insulin-like Growth Factors and Cancer , 1995, Annals of Internal Medicine.

[17]  B. Haber,et al.  Characterization of a Human Pancreatic Carcinoid in Vitro: Morphology, Amine and Peptide Storage, and Secretion , 1994, Pancreas.

[18]  E. Theodorsson,et al.  Presence of IGF‐I In human midgut carcinoid tumours—an autocrine regulator of carcinoid tumour growth? , 1992, International journal of cancer.

[19]  V. Macaulay,et al.  Insulin-like growth factors and cancer. , 1992, British Journal of Cancer.

[20]  O. Nilsson,et al.  Immunocytochemical evidence for the presence of IGF-I and IGF-I receptors in human endocrine tumours. , 1992, Acta physiologica Scandinavica.

[21]  D. Yee,et al.  Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factor. , 1990, The Journal of clinical investigation.

[22]  W. Daughaday.  The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. , 1990, Endocrinology.

[23]  T. Berge,et al.  Carcinoid tumours. Frequency in a defined population during a 12-year period. , 2009, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.

[24]  J. Godwin.  Carcinoid Tumors An analysis of 2837 cases , 1975, Cancer.